Richard Nieman - Jul 11, 2022 Form 3 Insider Report for Lyra Therapeutics, Inc. (LYRA)

Role
Chief Medical Officer
Signature
/s/ Jason Cavalier, Attorney-in-Fact for Richard Nieman
Stock symbol
LYRA
Transactions as of
Jul 11, 2022
Transactions value $
$0
Form type
3
Date filed
7/12/2022, 04:05 PM
Next filing
Feb 2, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney.